Frazier O H
Cullen Cardiovascular Research Laboratories, Texas Heart Institute, Houston 77225-0345.
Semin Thorac Cardiovasc Surg. 1994 Jul;6(3):181-7.
The development of the portable, electrically powered LVAD was a complex process that began in the early 1970s with the left ventricular assist project sponsored by the National Institutes of Health. The problems that DeBakey outlined in 1971 that challenged widespread clinical use of a ventricular assist device have today largely been solved by the TCI portable, electrically powered LVAD. The cost of LVAD implantation and maintenance, although still considerable, is less than the cost of caring for a patient in an intensive care unit for 75 days (the median waiting time in 1992 for a UNOS Status I candidate [UNOS, personal communication, 1994]) and comparable with the cost of other devices in use, such as the internal defibrillator. Although the implantation of the LVAD still requires a major operation, it is now a commonly performed procedure in transplant centers that use LVADs, and the level of operative risk is considered acceptable. The operation to implant an LVAD is usually performed in patients for whom death is imminent, and the potential benefit to such patients is high in relation to the risk of the surgical procedure. DeBakey feared that textured blood-contacting surfaces might not be suitable over long periods, but this has not been the case.(ABSTRACT TRUNCATED AT 250 WORDS)
便携式电动左心室辅助装置(LVAD)的研发是一个复杂的过程,始于20世纪70年代初由美国国立卫生研究院赞助的左心室辅助项目。德贝基在1971年概述的那些阻碍心室辅助装置广泛临床应用的问题,如今在很大程度上已被TCI便携式电动LVAD解决。LVAD植入和维护的成本虽然仍然可观,但低于在重症监护病房护理患者75天的费用(1992年UNOS一级候选患者的中位等待时间[UNOS,个人通信,1994]),且与其他正在使用的装置(如植入式除颤器)的成本相当。虽然LVAD植入仍需要进行大手术,但现在在使用LVAD的移植中心,这已是一种常见的手术,且手术风险水平被认为是可接受的。植入LVAD的手术通常在濒临死亡的患者身上进行,对于这类患者而言,相对于手术风险,潜在益处很大。德贝基担心有纹理的血液接触表面长期来看可能不合适,但实际并非如此。(摘要截选于250词)